Angiogenesis in Glioblastoma—Treatment Approaches.

Authors: Nowacka, Agnieszka¹ (AUTHOR) a.nowacka@cm.umk.pl, Śniegocki, Maciej^1,2 (AUTHOR), Smuczyński, Wojciech^2,3 (AUTHOR), Bożiłow, Dominika^3,4 (AUTHOR), Ziółkowska, Ewa^1,4 (AUTHOR)

Source: Cells (2073-4409). Mar2025, Vol. 14 Issue 6, p407. 30p.

Subject Terms: *BRAIN tumors, *NEOVASCULARIZATION inhibitors, *OVERALL survival, *SURVIVAL rate, *GLIOBLASTOMA multiforme

Multiplex immunohistochemistry to explore the tumor immune microenvironment in HCC patients with different GPC3 expression.

Authors: Zhou, Mingzhen¹ (AUTHOR), Zhou, Ziyan¹ (AUTHOR), Hu, Lina¹ (AUTHOR), Chen, Sidong² (AUTHOR), Meng, Fanyan^1,3 (AUTHOR) fanyanmeng@hotmail.com, Chen, Jun⁴ (AUTHOR) ichenjun@qq.com, Shen, Jie^1,2 (AUTHOR) shenjie2008nju@163.com

Source: Journal of Translational Medicine. 1/21/2025, Vol. 23 Issue 1, p1-13. 13p.

Subject Terms: *MEDICAL sciences, *NEOVASCULARIZATION inhibitors, *IMMUNOHISTOCHEMISTRY, *T cells, *TUMOR microenvironment

New acorane-sesequiterpenes and anti-retinoblastoma constituents from the marine algicolous fungus Trichoderma harzianum NTU2180 guided by molecular networking strategy.

Authors: Gu, Andrea^1,2 (AUTHOR), Lin, Fan-Li^3,4 (AUTHOR), Lu, Chung-Kuang⁵ (AUTHOR), Yeh, Tz-Wei^1,5 (AUTHOR), Chen, Yih-Fung⁶ (AUTHOR), Wu, Ho-Cheng^2,7 (AUTHOR) hcwu@kmu.edu.tw, Lee, Tzong-Huei¹ (AUTHOR) thlee1@ntu.edu.tw

Source: Botanical Studies. 1/14/2025, Vol. 66 Issue 1, p1-13. 13p.

Subject Terms: *TRICHODERMA harzianum, *NEOVASCULARIZATION inhibitors, *LIFE sciences, *METABOLITES, *MARINE fungi

The Influence of Vitamin D Levels and Supplementation on the Treatment of Patients Affected by MRONJ.

Authors: Michalak, Filip¹, mifilip@wp.pl, Dominiak, Marzena¹, marzena.dominiak@umw.edu.pl, Kiryk, Jan¹, jan.kiryk@umw.edu.pl, Popecki, Paweł¹, pawel.popecki@umw.edu.pl, Kubicki, Dominik², kubickidonio@gmail.com, Matys, Jacek¹, jacek.matys@umw.edu.pl, Grzech-Leśniak, Kinga^1,3, jacek.matys@umw.edu.pl

Source: Applied Sciences (2076-3417); Jan2025, Vol. 15 Issue 2, p670, 14p

Combination of paclitaxel with rosiglitazone induces synergistic cytotoxic effects in ovarian cancer cells.

Authors: Patel, Binita¹ (AUTHOR), Patel, Shanaya² (AUTHOR), Modi, Foram³ (AUTHOR), Patel, Aditi² (AUTHOR), Gelat, Brijesh³ (AUTHOR), Tanavde, Vivek² (AUTHOR), Vasavada, Abhay⁴ (AUTHOR), Johar SR, Kaid³ (AUTHOR) kaidjohar@gujuni.ac.in

Source: Scientific Reports. 12/28/2024, Vol. 14 Issue 1, p1-13. 13p.

Subject Terms: *MEDICAL sciences, *NEOVASCULARIZATION inhibitors, *ANTINEOPLASTIC agents, *CANCER relapse, *OVARIAN cancer

Efficacy and safety of combining anti-angiogenic therapy, radiotherapy, and PD-1 inhibitors in patients with driver gene-negative non-small cell lung cancer brain metastases: a retrospective study.

Authors: Zhang, Xianwen¹ (AUTHOR), Sun, Qian¹ (AUTHOR), Chen, Rujun¹ (AUTHOR), Zhao, MengDie¹ (AUTHOR), Cai, Feng¹ (AUTHOR), Cui, Zhen¹ (AUTHOR), Jiang, Hao¹ (AUTHOR) jianghao1223@163.com

Source: BMC Cancer. 12/3/2024, Vol. 24 Issue 1, p1-13. 13p.

Subject Terms: *NON-small-cell lung carcinoma, *NEOVASCULARIZATION inhibitors, *MEDICAL sciences, *BRAIN cancer, *INTRACRANIAL hemorrhage

Quality by design enabled formulation development of regorafenib monohydrate loaded PEGylated PLGA polymeric nanoparticles: Enhanced oral bioavailability and biopharmaceutical attributes.

Authors: Panigrahi, Dhananjay¹, Swain, Suryakanta² swain_suryakant@yahoo.co.in, Sahu, Pratap Kumar¹, Ghose, Debashish³, Jena, Bikash Ranjan⁴

Source: Nanomedicine Journal. Autumn2024, Vol. 11 Issue 4, p401-416. 16p.

Subject Terms: *COLON cancer, *NEOVASCULARIZATION inhibitors, *PARTICLE size distribution, *NANOPARTICLES, *REGORAFENIB

Urine Protein to Creatinine Ratio for the Assessment of Bevacizumab-Associated Proteinuria in Patients with Gynecologic Cancers: A Diagnostic and Quality Improvement Study.

Authors: Huang, Kuan-Ju^1,2 (AUTHOR), Chang, Wen-Chun^2,3 (AUTHOR), Chen, Chi-Hau³ (AUTHOR), Lin, Wei-Chen⁴ (AUTHOR), Pan, William Wei-Lin⁵ (AUTHOR), Hsieh, Hao-I.⁵ (AUTHOR), Hsieh, Yu-Hsiung³ (AUTHOR), Wei, Lin-Hung³ (AUTHOR), Sheu, Bor-Ching³ (AUTHOR) bcsheu@ntu.edu.tw

Source: Diagnostics (2075-4418). Sep2024, Vol. 14 Issue 17, p1852. 10p.

Subject Terms: *CHRONIC kidney failure, *NEOVASCULARIZATION inhibitors, *GYNECOLOGIC cancer, *ANTINEOPLASTIC agents, *DIET in disease

Pan-cancer integrative analyses dissect the remodeling of endothelial cells in human cancers.

Authors: Li, Jinhu¹ (AUTHOR), Wang, Dongfang¹ (AUTHOR) wangdf19@pku.edu.cn, Tang, Fei^1,2 (AUTHOR), Ling, Xinnan¹ (AUTHOR), Zhang, Wenjie¹ (AUTHOR), Zhang, Zemin^1,2 (AUTHOR) zemin@pku.edu.cn

Source: National Science Review. Sep2024, Vol. 11 Issue 9, p1-16. 16p.

Subject Terms: *ENDOTHELIAL cells, *NEOVASCULARIZATION inhibitors, *CXCR4 receptors, *CANCER patients, *RNA sequencing

A Splice Form of VEGF, a Potential Anti-Angiogenetic Form of Head and Neck Squamous Cell Cancer Inhibition.

Authors: Dumitru, Cristina Stefania¹ (AUTHOR) cristina-stefania.dumitru@umft.ro, Raica, Marius¹ (AUTHOR)

Source: International Journal of Molecular Sciences. Aug2024, Vol. 25 Issue 16, p8855. 16p.

Subject Terms: *VASCULAR endothelial growth factor receptors, *NEOVASCULARIZATION inhibitors, *SQUAMOUS cell carcinoma, *MOLECULAR structure, *INDIVIDUALIZED medicine

Combination of Sintilimab and Anlotinib for Metastatic Osteosarcoma: A Case Report.

Authors: Tang, Gaoyan (AUTHOR), Zhang, Qianqian (AUTHOR), Wang, Fengxia (AUTHOR), Zhang, Hua (AUTHOR), Qi, Yuanling (AUTHOR)

Source: OncoTargets & Therapy. Aug2024, Vol. 17, p661-665. 5p.

Subject Terms: *NEOVASCULARIZATION inhibitors, *YOUNG adults, *ANLOTINIB, *OSTEOSARCOMA, *PROGNOSIS

Intravitreal Antiangiogenic Treatment for Diabetic Retinopathy: A Mexican Real-Life Scenario Experience.

Authors: López-Letayf, Sonia^1,2 (AUTHOR) dra.vlondono@gmail.com, Vivanco-Rojas, Oscar^1,2 (AUTHOR) fatima.magana@institutodeoftalmologia.org, Londoño-Angarita, Valentina² (AUTHOR) bbuentello@institutodeoftalmologia.org, Magaña-Guerrero, Fátima Sofía² (AUTHOR), Buentello-Volante, Beatriz² (AUTHOR), Garfias, Yonathan^1,2 (AUTHOR) ygarfias@bq.unam.mx

Source: Life (2075-1729). Aug2024, Vol. 14 Issue 8, p976. 11p.

Subject Terms: *DIABETIC retinopathy, *NEOVASCULARIZATION inhibitors, *INTRAVITREAL injections, *DIABETES complications, *MEXICANS, *RANIBIZUMAB

Efficacy comparison of immune combination therapies in subgroups for advanced hepatocellular carcinoma patients: Systematic review and network meta-analysis.

Authors: Wang, Yani¹ (AUTHOR), Lau, Wanyee² (AUTHOR), Li, Yafei³ (AUTHOR), Tian, Yichen¹ (AUTHOR), Lei, Yongrong¹ (AUTHOR), Xia, Feng⁴ (AUTHOR) wjh@cqu.edu.cn, Wang, Jianhua¹ (AUTHOR) wjh@cqu.edu.cn

Source: PLoS ONE. 7/22/2024, Vol. 19 Issue 7, p1-15. 15p.

Subject Terms: *HEPATOCELLULAR carcinoma, *NEOVASCULARIZATION inhibitors, *ALPHA fetoproteins, *VIRAL hepatitis, *PROTEIN-tyrosine kinase inhibitors

Phytochemical Evaluation and Anti-angiogenic Activity of Alingatong (Dendrocnide meyeniana Walp.) Root Extracts Using the Chorioallantoic Membrane Assay on Duck Embryo.

Authors: Torno, Ezra Maurel D.^1,2, Subebe, Merrah Joy B.², Manting, Muhmin Michael E.¹, Villacorte-Tabelin, Mylah^1,2 mylah.tabelin@g.msuiit.edu.ph

Source: Malaysian Applied Biology. Jun2024, Vol. 53 Issue 2, p72-80. 9p.

Subject Terms: *PLANT extracts, *NEOVASCULARIZATION inhibitors, *CHORIOALLANTOIS, *ARTEMIA, *BIOACTIVE compounds, *PHYTOCHEMICALS

Effect of novel anti-tumor and anti-angiogenesis drug taurolactone on angiogenic factor AGGF1 and angiogenesis mimicry in patients with hepatocellular carcinoma.

Authors: Liu, Shaoping¹ (AUTHOR), Wei, Yinzhi¹ (AUTHOR), Nie, Lei² (AUTHOR), Tang, Ze³ (AUTHOR), Lu, Qi⁴ (AUTHOR), Liang, Qun¹ (AUTHOR) 3344871925@qq.com

Source: BMC Cancer. 5/21/2024, Vol. 24 Issue 1, p1-9. 9p.

Subject Terms: *VASCULAR endothelial growth factors, *NEOVASCULARIZATION inhibitors, *ANTINEOPLASTIC agents, *NEOVASCULARIZATION, *OVERALL survival, *BRONCHIAL carcinoma, *HEPATOCELLULAR carcinoma

Characterization of FOLH1 Expression in Renal Cell Carcinoma.

Authors: Ovruchesky, Eric¹ (AUTHOR), Pan, Elizabeth¹ (AUTHOR), Guer, Melis¹ (AUTHOR), Elliott, Andrew² (AUTHOR), Siva, Shankar³ (AUTHOR), Ravi, Praful⁴ (AUTHOR), McGregor, Bradley⁴ (AUTHOR), Bagrodia, Aditya¹ (AUTHOR), Derweesh, Ithaar¹ (AUTHOR), Barata, Pedro⁵ (AUTHOR), Heath, Elisabeth I.⁶ (AUTHOR), Antonarakis, Emmanuel S.⁷ (AUTHOR), Darabi, Sourat⁸ (AUTHOR), Hoon, Dave S. B.⁹ (AUTHOR), Mortazavi, Amir¹⁰ (AUTHOR), Choueiri, Toni K.⁴ (AUTHOR), Nabhan, Chadi² (AUTHOR), Wei, Shuanzeng¹¹ (AUTHOR), McKay, Rana R.¹ (AUTHOR) rmckay@health.ucsd.edu

Source: Cancers. May2024, Vol. 16 Issue 10, p1855. 15p.

Subject Terms: *RESEARCH funding, *NEOVASCULARIZATION inhibitors, *DESCRIPTIVE statistics, *TREATMENT duration, *GLYCOPROTEINS, *GENE expression, *KAPLAN-Meier estimator, *MEMBRANE glycoproteins, *RENAL cell carcinoma, *PROSTATE-specific membrane antigen, *ENDOTHELIAL cells

HGFK1 Enhances the Anti-Tumor Effects of Angiogenesis Inhibitors via Inhibition of CD90+ CSCs in Hepatocellular Carcinoma.

Authors: Li, Tao¹ (AUTHOR) litaove@163.com, Liu, Ling² (AUTHOR), Li, Li¹ (AUTHOR), Yao, Xiaoxuan¹ (AUTHOR), Hu, Xiaoyuan¹ (AUTHOR), Cheng, Jiaxing¹ (AUTHOR), Chen, Zhenpu¹ (AUTHOR), Guo, Jiyin¹ (AUTHOR), Li, Ruilei¹ (AUTHOR), Ge, Chunlei¹ (AUTHOR), Lin, Marie Chia-Mi¹ (AUTHOR), Yao, Hong^1,2 (AUTHOR) yaohong20055@hotmail.com

Source: Pharmaceuticals (14248247). May2024, Vol. 17 Issue 5, p645. 19p.

Subject Terms: *NEOVASCULARIZATION inhibitors, *HEPATOCYTE growth factor, *HEPATOCELLULAR carcinoma, *CANCER stem cells, *IMMUNE checkpoint inhibitors, *ENDOSTATIN

Gli1-mediated tumor cell-derived bFGF promotes tumor angiogenesis and pericyte coverage in non-small cell lung cancer.

Authors: Lei, Xueping¹ (AUTHOR), Li, Zhan¹ (AUTHOR), Huang, Manting² (AUTHOR), Huang, Lijuan¹ (AUTHOR), Huang, Yong¹ (AUTHOR), Lv, Sha¹ (AUTHOR), Zhang, Weisong¹ (AUTHOR), Chen, Zhuowen¹ (AUTHOR), Ke, Yuanyu¹ (AUTHOR), Li, Songpei¹ (AUTHOR), Chen, Jingfei¹ (AUTHOR), Yang, Xiangyu¹ (AUTHOR), Deng, Qiudi³ (AUTHOR) dengqiudi@gzhmu.edu.cn, Liu, Junshan^4,5 (AUTHOR) liujunshan@smu.edu.cn, Yu, Xiyong¹ (AUTHOR) yuxycn@gzhmu.edu.cn

Source: Journal of Experimental & Clinical Cancer Research (17569966). 3/16/2024, Vol. 43 Issue 1, p1-18. 18p.

Subject Terms: *NON-small-cell lung carcinoma, *NEOVASCULARIZATION inhibitors, *NEOVASCULARIZATION, *PROTEIN stability

177 Lu Anti-Angiogenic Radioimmunotherapy Targeting ATP Synthase in Gastric Cancer Model.

Authors: Park, Bok-Nam¹, curies@ajou.ac.kr, An, Young-Sil¹, Kim, Su-Min¹, Lee, Su-Jin¹, Park, Yong-Jin¹, Yoon, Joon-Kee¹, jkyoon3@ajou.ac.kr

Source: Antibodies (2073-4468); Sep2024, Vol. 13 Issue 3, p51, 15p

Therapeutic Targeting of Hypoxia-Inducible Factors in Cancer.

Authors: Musleh Ud Din, Saba¹ (AUTHOR) smuslehuddin@mhs.net, Streit, Spencer G.² (AUTHOR) sstreit@mhs.net, Huynh, Bao Tran³ (AUTHOR), Hana, Caroline² (AUTHOR) chana@mhs.net, Abraham, Anna-Ninny² (AUTHOR) anabraham@mhs.net, Hussein, Atif² (AUTHOR) ahussein@mhs.net

Source: International Journal of Molecular Sciences. Feb2024, Vol. 25 Issue 4, p2060. 15p.

Subject Terms: *HYPOXIA-inducible factors, *NEOVASCULARIZATION inhibitors, *VASCULAR endothelial growth factors, *VON Hippel-Lindau disease, *GLUCOSE metabolism